Biotechnology Healthcare Medical Technology 
Bill Of Health
SEPTEMBER 13, 2023
These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from Harvard Law School. Prior to law school, she worked at the largest provider of disability and reproductive healthcare services in Dar es Salaam, Tanzania. Adithi Iyer is a law student (J.D.
Bill Of Health
MAY 20, 2024
By Marcelo Corrales Compagnucci Extended Reality (XR) technologies like Virtual Reality (VR), Augmented Reality (AR), and Mixed Reality (MR), are revolutionizing healthcare. However, integrating XR and AI into healthcare comes with ethical, legal and liability challenges.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill Of Health
OCTOBER 27, 2023
The HIPAA Problem The privatization of next-generation medical technologies, especially in regenerative and precision medicine, further muddies the data-protection waters. The innovation-security tradeoff is a familiar trope in biotechnology, but the main character of the direct-to-consumer tissue-based service story is less so.
Bill Of Health
SEPTEMBER 22, 2022
These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from across Harvard. He is deeply interested in the legal issues posed by the rise of artificial intelligence in the healthcare sector, especially as it pertains to intellectual property rights.
Bill Of Health
NOVEMBER 10, 2022
The following post is adapted from the edited volume AI in eHealth: Human Autonomy, Data Governance and Privacy in Healthcare. The emergence of digital platforms and related technologies are transforming healthcare and creating new opportunities and challenges for all stakeholders in the medical space.
Bill Of Health
SEPTEMBER 16, 2024
His research interests include structural determination and competence in mental healthcare, psychiatric ethics and pedagogy in psychiatric medicine. 2026) research interests include innovative medical technologies and chronic disease policy. Prior to law school, she worked as an analyst at ClearView Healthcare Partners.
Bill Of Health
MARCH 23, 2023
Is research in the interest of the public domain an activity exclusively developed by academic or healthcare entities, or can it be carried out by industry (pharmaceutical, biotechnology, technology companies, medical technology industries, and insurance providers)? If so, how?
Expert insights. Personalized for you.
59 
Let's personalize your content